LINDEN ADVISORS LP - TRINITY BIOTECH INVT LTD ownership

TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 1 filers reported holding TRINITY BIOTECH INVT LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LINDEN ADVISORS LP ownership history of TRINITY BIOTECH INVT LTD
ValueSharesWeighting
Q3 2019$8,947,000
+1.4%
12,015,0000.0%0.12%
-10.4%
Q2 2019$8,822,000
-4.9%
12,015,0000.0%0.14%
-36.3%
Q1 2019$9,272,000
-0.7%
12,015,0000.0%0.21%
-18.8%
Q4 2018$9,335,000
+0.3%
12,015,0000.0%0.26%
-7.8%
Q3 2018$9,303,000
-5.9%
12,015,0000.0%0.28%
-7.2%
Q2 2018$9,891,000
+1.9%
12,015,0000.0%0.30%
+32.6%
Q1 2018$9,709,000
+9.8%
12,015,000
+8.8%
0.23%
-11.9%
Q4 2017$8,843,000
-0.5%
11,040,0000.0%0.26%
-17.1%
Q3 2017$8,890,000
-1.3%
11,040,0000.0%0.32%
-17.1%
Q2 2017$9,010,000
+28.1%
11,040,000
+28.5%
0.38%
+45.6%
Q1 2017$7,034,000
-3.9%
8,590,0000.0%0.26%
-8.7%
Q4 2016$7,321,0008,590,0000.29%
Other shareholders
TRINITY BIOTECH INVT LTD shareholders Q3 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of TRINITY BIOTECH INVT LTD shareholders